Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • mikecz
    Junior Member
    • Jan 2012
    • 5

    Differential Expression across libraries/platforms

    I've been searching for a while now and I can't seem to find any kind of discussion on this topic.

    Is there any consensus on the most appropriate way (if any) to calculate differential expression of transcripts with samples derived from different library preparation methods or from different sequencing platforms?

    I have a few Illumina Hiseq 2000 100bp PE RNA-seq samples that can be considered biological replicates, but not quite technical replicates since some are from Truseq stranded libraries with others from Truseq unstranded preps. The problem is more complex yet since the unstranded samples have ~150 million read pairs and the stranded samples only 25 million.

    So far I've used the stranded reads for de novo transcriptome assembly, then used both the stranded and unstranded reads for mapping and quantification. Treating them in the same way by ignoring strand information with Bowtie and allowing for unpaired mapping when concordant mapping isn't possible gives me pretty horrible expression correlations after RSEM.

    Is there a normalization method that can compensate for the different biases in library preparation?
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    Just treat all of the samples as you would normally and treat the technology type/library-prep-kit as a batch variable (or two) in your model design.

    Of course, if whatever you're actually interested in measuring is partitioned across these then you're probably SOL.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM
    • GATTACAT
      Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
      by GATTACAT
      Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
      07-01-2026, 11:43 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    22 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    32 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-07-2026, 11:05 AM
    0 responses
    34 views
    0 reactions
    Last Post SEQadmin2  
    Working...